The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Drug-Coated Balloons Market Across 2026–2030?
The market size for drug-coated balloons has experienced rapid expansion over recent years. This market is projected to expand, climbing from $1.24 billion in 2025 to $1.43 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.5%. Historically, this growth can be attributed to factors such as the rising incidence of cardiovascular diseases, the broadening scope of interventional cardiology procedures, the initial embrace of paclitaxel-coated balloons, an increasing need for preventing restenosis, and continuous innovations in angioplasty techniques.
The drug-coated balloons market is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $2.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.6%. This expansion throughout the forecast period is primarily driven by factors such as the expanding application of DCB therapies in coronary procedures, the increasing embrace of advanced coating technologies, the proliferation of catheter-based interventional methods, heightened investments directed towards vascular innovation, and a growing patient preference for treatment alternatives that do not involve stents. Key trends anticipated during this period encompass the wider acceptance of sirolimus-coated balloons, an increase in the utilization of DCBs for peripheral artery disease, a stronger inclination towards less invasive vascular treatment approaches, the further development of sophisticated drug-coating technologies, and an intensified focus on enhancing the effectiveness of drug delivery.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp
Which Market Drivers Are Supporting The Expansion Of The Drug-Coated Balloons Market?
The rising prevalence of ambulatory surgery centers is projected to drive the expansion of the drug-coated balloon market in the coming years. An Ambulatory Surgical Center (ASC) is defined as a medical establishment focused on executing surgical procedures that do not necessitate an overnight hospital admission. Drug-coated balloons hold significant importance in ambulatory surgery centers (ASC) due to their characteristic of offering shorter procedure durations compared to conventional balloons, which in turn leads to improved patient capacity and reduced operational expenditures within ASCs. For example, in March 2025, the Medicare Payment Advisory Commission (an independent U.S. federal advisory agency) indicated that from 2022 through 2023, the count of Medicare-certified ASCs climbed 2.5% to 6,308 ASCs, demonstrating a net addition of 155 facilities throughout 2023. Thus, the increasing number of ambulatory surgery centers is propelling the growth of the drug-coated balloon market.
What Segmentation Levels Are Considered In The Drug-Coated Balloons Market?
The drug-coated balloons market covered in this report is segmented –
1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease
2) By Drug Type: Paclitaxel, Sirolimus
3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers
Subsegments:
1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
What Trends Are Projected To Affect The Drug-Coated Balloons Market?
Leading companies engaged in the development of drug-coated balloons are actively working on enhancing their technologies, such as paclitaxel-coated balloon catheters, to improve the effectiveness of treatments for conditions like coronary in-stent restenosis, thereby boosting patient outcomes and mitigating the risks of complications associated with traditional therapies. Paclitaxel-coated balloon catheters are medical instruments that release the drug paclitaxel into the artery wall when expanded, which helps prevent re-narrowing after angioplasty. For instance, in March 2024, Boston Scientific Corporation, a US-based medical device company, obtained US Food and Drug Administration (FDA) approval for its AGENTTM Drug-Coated Balloon (DCB). This device is engineered for managing coronary in-stent restenosis (ISR) in patients with coronary artery disease, a condition characterized by the obstruction or narrowing of a stented blood vessel due to plaque or scar tissue.
Which Leading Firms Are Contributing To The Growth Of The Drug-Coated Balloons Market?
Major companies operating in the drug-coated balloons market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, Biosensors International Group Ltd, Concept Medical Inc., Acotec Scientific AG, Cardionovum GmbH, MedAlliance SA, iVascular SLU, Minvasys SAS, QT Vascular Ltd, Hexacath SAS, Cordis Corporation, MicroPort Scientific Corporation, Endocor GmbH, Orchestra BioMed Inc., Lepu Medical Technology Co. Ltd, Balton Sp. z o.o., BrosMed Medical Co. Ltd
Read the full drug-coated balloons market report here:
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report
How Is The Drug-Coated Balloons Market Distributed Across Key Geographic Regions?
North America was the largest region in the global drug-coated balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Drug-Coated Balloons Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp
Browse Through More Reports Similar to the Global Drug-Coated Balloons Market 2026, By The Business Research Company
Drug Eluting Balloons Catheters Market Report 2026
Intragastric Balloons Market Report 2026
https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report
Angioplasty Balloons Market Report 2026
https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model